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An unusual initial presentation of mantle
cell lymphoma arising from the lymphoid
stroma of warthin tumor
Ramir S. Arcega1*, Aaron J. Feinstein2, Sunita Bhuta1, Keith E. Blackwell2, Nagesh P. Rao1 and Sheeja T. Pullarkat1
Abstract
Background: Warthin tumors presenting concomitantly with a lymphoma is vanishingly rare with only 15 reported
cases in English literature. Herein, we report an unusual initial presentation of a mantle cell lymphoma involving the
lymphoid stroma of a Warthin tumor.
Case presentation: A seventy-seven year old otherwise healthy gentleman with a 50-pack year smoking history presents
with a slowly enlarging left cheek mass. CT scan of the neck demonstrated a left parotid gland tumor measuring 3.4 cm in
greatest dimension. He underwent a left superficial parotidectomy, with subsequent histopathologic examination revealing a
Warthin tumor with extensive expansion of the lymphoid stroma. Flow cytometric, immunohistochemical, and cytogenetic
studies of the stromal component of the tumor confirmed the presence of a mantle cell lymphoma. Clinical staging
demonstrated stage IVa disease, and was considered to be at low to intermediate risk due to the slow growth of the
parotid lesion. The patient is undergoing close follow up with repeat PET-CT scans at six months.
Conclusion: To the best of our knowledge, this is the first well documented collision tumor between mantle cell lymphoma
and a Warthin tumor. This case also brings to light the significance of thorough evaluation of the lymphoid component of
Warthin tumor.
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Background
Warthin tumor is the second most common benign tumor
of the salivary gland [1]. The tumor is characterized by an
epithelial component composed mainly of tall bilayered
oncocytic columnar cells embedded within a lymphoid
stroma [1, 2]. Lymphoma involving the stromal component
is extremely rare, with the majority of those that have been
described are in the setting of a widely disseminated lymph-
oma. Herein we describe a case of mantle cell lymphoma
that primarily presented as part of the Warthin Tumor (i.e.,
a collision tumor). Karyotype studies detected the character-
istic t(11;14)(q13;q32) translocation as part of a complex
karyotype, and corroborated by immunohistochemistry stud-
ies. This case emphasizes the importance of a thorough
evaluation of the lymphoid stroma of a Warthin Tumor,
since the lymphoma cells can be easily confused with a nor-
mal reactive lymphoid component within the tumor.
Case presentation
A 70 year old otherwise healthy male patient with a 50-pack
year smoking history who quit approximately 3 years ago,
presented with a slowly enlarging left cheek mass. He first
noted the lesion approximately 1 year prior to presentation.
The patient reported undergoing a fine needle aspiration
at an outside facility at which time some fluid was drained
from the cheek mass, but the mass later re-accumulated.
Over time he developed mild local pain and ipsilateral left
ear discomfort. Contrast enhanced CT-scan of the neck
demonstrated a left parotid gland tumor measuring
3.3 cm (anterior-posterior) × 2.2 cm (transverse) × 3.4 cm
(craniocaudal) without pathologic cervical adenopathy
(Fig. 1). The facial nerve function was intact, with a House-
Brackmann score of 1 out of 6. The patient underwent a left
superficial parotidectomy with a left sternocleidomastoid
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muscle flap reconstruction. He was discharged home on
postoperative day 2 following an uneventful hospital course.
Facial nerve function was full postoperatively. A complete
blood count was within normal range at the time of
diagnosis.
Pathologic findings
Gross examination of the left superficial parotidectomy spe-
cimen demonstrated a tan-red ovoid specimen with a lobu-
lated external surface that measured 5.2 × 4.2 × 3.8 cm.
Sectioning revealed a single well-circumscribed homoge-
neous tan mass measuring 4.1 × 2.2 × 2.1 cm (Fig. 2). Cut
surfaces of the lesion had a homogeneous tan “fish-flesh”
appearance. The uninvolved parenchyma was tan-red and
lobulated.
Microscopic examination revealed an intraparenchymal
lesion composed of both epithelial and lymphoid elements
encased within a thin fibrous capsule, sharply demarcated
from the adjacent uninvolved salivary gland parenchyma
(Fig. 3a). The epithelial component was composed of a
double layer of tall columnar oncocytic cells with bland cy-
tologic features arranged in a vague papillary and rare cystic
architecture, both of which were compressed by the mark-
edly expanded lymphoid stroma with rare secondary folli-
cles seen (Fig. 3b). The lymphoid stroma was composed of
small to medium sized lymphocytes with clumped to ves-
icular chromatin pattern, irregular nuclear contours, indis-
tinct nucleoli, and scant cytoplasm (Fig. 3c and d). Mitoses
and necrosis were inconspicuous. Lymphoepithelial lesions
were not identified. Immunohistochemical stains showed
the neoplastic cells positive for CD5 (weak), CD20, PAX5,
Cyclin D1, BCL2, and negative for CD10, CD23, and BCL6
(Fig. 4a–e). The Ki67 proliferation index was estimated at
approximately 40 % (Fig. 4f).
Flow cytometric studies of the mass demonstrated a
kappa-restricted B-cell population co-expressing CD20, CD5
(dim), PAX5, FMC7, CD19, and negative for CD10 and
CD23 (Fig. 5a–d). Flow cytometry was not performed on
peripheral blood. The karyotype studies from cultured cells
revealed a complex karyotype in 2 of 20 cells analyzed:
47,XY,del(1)(p36.1),ins(5;13)(q35;q12q32),add(8)(p21),
t(11;14)(q13;q32),+18[2]/46,XY[19] with the characteristic
t(11;14) translocation (Fig. 6). FISH analysis with the
dual-color dual fusion IGH-CCND1 probes identified
dual fusion signals (yellow) confirming the presence of
a reciprocal t(11;14)(q13;q32) (Fig. 5e–f ). Both karyotype
and FISH studies were performed on the tissue mass.
Discussion
After a thorough review of the English literature we conclude
that this is the first case of a mantle cell lymphoma present-
ing within the lymphoid stroma of a Warthin tumor that
LEFT
ANTERIOR
Fig. 1 Computed tomography of neck soft tissue demonstrates an
enhancing mass (white arrow) within the left parotid gland measuring
3.3 cm (anterior-posterior) × 2.2 cm (transverse) × 3.4 cm (craniocaudal).
No enlarged lymph nodes or abnormal fluid collections are seen
Fig. 2 Gross photograph of a cut section of the parotid gland
demonstrating a well circumscribed, homogeneous, tan lesion
surrounded by a rim of normal salivary gland parenchyma (scale shown)
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Fig. 3 Mantle cell lymphoma arising from Warthin tumor stroma. a Histologic sections of the parotid gland demonstrate a well circumscribed lesion with
a thin fibrous capsule that is sharply delineated from the adjacent uninvolved salivary gland parenchyma, with an expanded lymphoid stroma showing
rare secondary follicular structures. b Higher magnification demonstrates the characteristic dual layered oncocytic cells of Warthin tumor. c The stromal
lymphocytes are small to medium in size, with higher magnification (d) demonstrating clumped to vesicular chromatin patterns, irregular nuclear
contours, inconspicuous to small distinct nucleoli, and scant clear cytoplasm. Hemotoxylin-eosin stain, original magnification 20× (a) 200× (b), 400× (c),
and 1000× (d)
Fig. 4 Immunohistochemical stains demonstrate the neoplastic lymphoid cells positive for a CD20, b PAX5, c Cyclin D1, d CD5, weak, e and
BCL2. The Ki67 proliferation index (F) was estimated at 40 %. Immunohistochemical stain, original magnification,400× (a–f)
Arcega et al. Diagnostic Pathology  (2015) 10:209 Page 3 of 6
e f
Abnormal cells with two fusion signals (yellow) 
consistent with reciprocal t(11;14)(q13;q32)
Normal cells with two IGH 
(green) and two CCND1 
(red) signals
a b
c d
Fig. 5 Flow cytometry performed on the specimen demonstrate a kappa-restricted B-cell population (a) and (b) co-expressing (c) CD5 and (d)
are negative for CD23. e FISH studies using CCND1 (11q13 red); IGH (14q32 green) dual color-dual fusion probes - normal control, f FISH studies
with lymphoma cells showing CCND1-IGH (yellow) fusion signal
Fig. 6 Chromosomal analysis showing t(11;14) [involved chromosomes in box] in association with a complex karyotype. Arrows highlight
chromosome abnormalities (see text)
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was diagnosed at the time of histopathological assessment of
a Warthin tumor excision. We were able to locate other
case reports of non-Hodgkin lymphomas within Warthin
tumor (15 cases, Table 1) [3–15] with eleven follicular
lymphomas [3–7, 10–13], two chronic lymphocytic
leukemia/small lymphocytic leukemia [9, 14], one Hodgkin
lymphoma [8], and one T-Lymphoblastic Lymphoma [15].
A report from 1980 described a mantle cell lymphoma
(formerly known as malignant centrocytic lymphoma) arising
within a parotid gland with chronic myoepithelial parotitis,
with an adjacent 0.5 cm Warthin tumor (cystadenolym-
phoma) as a secondary finding, but the lymphoma was not
described to arise from within the lymphoid stroma of the
tumor [16] as seen in the current case. In addition, since the
reported case was diagnosed in 1980, the diagnosis was
based on morphology alone, with no immunophenotypic
support or establishment of t(11;14)(q13; q32).
Warthin tumors are the second most common benign
salivary gland tumor, with an average age at presentation
of 62 years old, and have rarely been described before
the age of 40 [1]. A strong association between smoking
and Warthin tumors has been described, with an esti-
mated incidence of eight times compared to that of non-
smokers [17]. The male to female ratio was 10:1 in 1953,
whereas it was 1.2:1 in 1996 [1], which parallels the lar-
ger number of female smokers during this period [2].
Despite quitting smoking a few years prior to his
presentation, our patient had an established 50-pack year
smoking history. The patient denied other possible risk
factors that have been linked to Warthin tumors, such
as radiation exposure and autoimmune disorder.
Biologically it is quite feasible that lymphomas may
arise within a Warthin tumor, since the lymphoid stroma
is part of the systemic lymphoid tissue, and hence may
be involved in disseminated lymphomatous involvement.
Of the reported cases of lymphomas within Warthin
tumors, the majority of patients either already had an estab-
lished diagnosis at presentation, or systemic involvement was
discovered at staging after initial diagnosis in the Warthin
tumor.
Although patients with mantle cell lymphoma have a
median survival of 3–5 years, with the vast majority of
these patients not cured despite treatment [18], the
prognosis of those which arise from within the confines
of another tumor is virtually unknown. The most con-
sistent histopathologic prognostic parameter is a high
mitotic rate, which is defined as 10–37.5/15 hpf, with a
high proportion of Ki67 positive cells (>40 % to 60 %)
also an adverse prognostic indicator [18]. Blastoid and
pleomorphic morphology, trisomy 12, and karyotypic
complexity(≥ three or more chromosomal aberrations),
have all been reported to have adverse prognostic fea-
tures [18]. Despite the lack of observed mitotic activity in
the current case, the Ki67 proliferative index was esti-
mated to be 40 %. Blastoid and pleomorphic morphology
was not evident. Although gains of chromosome 3q and
deletions of 9q, both associated with poor prognosis were
not seen in the current case, a complex karyotype was
observed.
A thorough clinical staging is warranted in patients
with mantle cell lymphoma, since most patients present
with stage III or IV disease [18]. The patient was referred
to his local medical oncologist. He had whole body diag-
nostic and contrast-enhanced CT imaging followed by
FDG administration and PET image acquisition, which
disclosed hypermetabolism in the left parotid area and a
single liver lesion, likely representing metastatic disease,
without other adenopathy. Bone marrow biopsy revealed
2 % involvement by B-cell lymphoma. He was staged
as Stage IVa. Patient was considered to be at low-inter-
mediate risk due to the slow growth of the parotid le-
sion, and elected to undergo close observation with
plans for repeat PET-CT at 6 months.
Conclusion
In summary, initial presentation of a malignant lymph-
oma within the lymphoid stroma of a Warthin tumor is
extremely rare. This is the first reported case of a colli-
sion tumor presenting with mantle cell lymphoma and
Warthin tumor. Emphasis must be made for a thorough
Table 1 Summary of 15 cases of non-Hodgkin lymphoma
involving Warthin tumor
Author (year) Sex Age Location Lymphoma
Colby and
Dorfman (1979)
NA NA Parotid FL
Miller (1982) M 49 Right Mandible FL
Hall (1985) M 64 Right Parotid FL
Banik (1985) M 75 Left Parotid FL
M 76 Right Parotid FL
Griesser (1986) F 64 Palate FL
Melato (1986) M 69 Right Parotid Hodgkin Lymphoma
Bunker and
Locker (1989)
F 63 Left Parotid SLL/CLL
Giardini and
Mastore (1990)
M 57 Left and Right
Parotid
FL
Medeiros (1990) M 71 Left Parotid FL
Shikhani (1993) M 56 Right Parotid FL
Park (2000) F 68 Right Parotid FL
M 55 Right Parotid FL
Saxena (2005) M 60 Left Parotid SLL/CLL
Giaslakiotis
(2009)
M 81 Right Parotid T-LBL
FL Folliclar Lymphoma
SLL/CLL Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
T-LBL T-Lymphoblastic Lymphoma
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examination of the lymphoid component in a Warthin
tumor as clearly exemplified by our case.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and is available upon
request.
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